Nitromist is a drug owned by Evus Health Solutions Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Apr 16, 2016. Details of Nitromist's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5869082 | Buccal, non-polar spray for nitroglycerin |
Apr, 2016
(8 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Nitromist is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Nitromist's family patents as well as insights into ongoing legal events on those patents.
Nitromist's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Nitromist's generic launch date based on the expiry of its last outstanding patent is estimated to be Apr 16, 2016 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Nitromist Generic API suppliers:
Nitroglycerin is the generic name for the brand Nitromist. 26 different companies have already filed for the generic of Nitromist, with Mylan Technologies having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Nitromist's generic
Alternative Brands for Nitromist
There are several other brand drugs using the same active ingredient (Nitroglycerin) as Nitromist. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | ||
|---|---|---|---|
| Abbvie |
| ||
| Pohl Boskamp |
| ||
| Viatris |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Nitroglycerin, Nitromist's active ingredient. Check the complete list of approved generic manufacturers for Nitromist
About Nitromist
Nitromist is a drug owned by Evus Health Solutions Llc. Nitromist uses Nitroglycerin as an active ingredient. Nitromist was launched by Evus in 2006.
Approval Date:
Nitromist was approved by FDA for market use on 02 November, 2006.
Active Ingredient:
Nitromist uses Nitroglycerin as the active ingredient. Check out other Drugs and Companies using Nitroglycerin ingredient
Dosage:
Nitromist is available in aerosol, metered form for sublingual use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 0.4MG/SPRAY | AEROSOL, METERED | Prescription | SUBLINGUAL |